Colgate-Palmolive Company (CL) Financial Statements

Historical financial data — 42 statements covering FY2016–FY2025

Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 4...

Colgate-Palmolive Company's revenue increased 1.4% year over year, from $20.10B to $20.38B.

Net income decreased 26.2% over the same period, from $2.89B to $2.13B.

Over the 9-year period from FY2016 to FY2025, revenue grew by 34% in total.

Total debt decreased by 5.7% to $6.87B.

The debt-to-equity ratio stands at 127.24, indicating a high leverage profile.

Operating cash flow grew 2.2% to $4.20B.

Colgate-Palmolive Company maintains a healthy net profit margin of 10.5%.

Recent Financial Statements

Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).

PeriodRevenueNet IncomeGross ProfitEBITOp. Cash FlowTotal AssetsTotal DebtEquity
Q3 FY2024$5.03B-0.5%$736.0M$3.07B$1.07B$1.17B$16.77B$7.91B$435.0M
Q4 FY2024$4.95B-1.7%$739.0M$2.98B$1.06B$1.27B$16.05B$7.29B$212.0M
Q1 FY2025$4.91B-0.7%$690.0M$2.99B$1.08B$600.0M$16.65B$6.57B$363.0M
Q2 FY2025$5.11B+4.1%$743.0M$3.07B$1.08B$884.0M$17.47B$7.14B$702.0M
Q3 FY2025$5.13B+0.4%$736.0M$3.05B$1.06B$1.26B$17.51B$7.31B$856.0M
Q4 FY2025$5.23B+1.9%$-37.0M$3.15B$92.0M$1.45B$16.33B$6.87B$54.0M
Q1 FY2026$5.32B+1.8%$646.0M$3.23B$964.0M$747.0M$16.61B$7.97B$486.0M
Q2 FY2026$5.36B+0.7%$693.0M$3.30B$1.02B$995.0M$16.79B$7.86B$566.0M

Balance Sheet Summary (Q2 FY2026)

Total Assets
$16.79B
Total Liabilities
$16.22B
Total Equity
$566.0M
Cash & Equivalents
$1.45B
Total Debt
$7.86B
Current Assets
$6.31B
Current Liabilities
$6.15B
Retained Earnings
$27.09B
Current Price: $94.50
Market Cap: $75.3B
Sector: Consumer Defensive

Colgate-Palmolive Company (CL) Financial Statements & Revenue History

Colgate-Palmolive Company (CL) is a US-listed stock operating in the Consumer Defensive sector, specifically the Perfumes, Cosmetics & Other Toilet Preparations industry trading at $94.50 with a market capitalization of $75. This page provides 42 historical financial statements for Colgate-Palmolive Company, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Colgate-Palmolive Company reported revenue of $20.4 billion, representing 1.4% year-over-year growth. The net profit margin of 10.5% indicates moderate profitability. The debt-to-equity ratio of 127.24 signals high leverage.

CL Income Statement, Balance Sheet & Cash Flow

The financial statements table above shows Colgate-Palmolive Company's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether CL is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.

  • Revenue trend: Track CL's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
  • Profitability: Net income and gross profit margins reveal how efficiently Colgate-Palmolive Company converts revenue into earnings.
  • Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of CL's financial position and leverage.
  • Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.

How to Use CL Financial Data

Investors use Colgate-Palmolive Company's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:

Financial data is sourced from Colgate-Palmolive Company's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.CL trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.

Related opportunities

Moving today in Consumer Defensive
More Perfumes, Cosmetics & Other Toilet Preparations stocks
Cheaper alternatives
Similar fundamentals